Grace Therapeutics, Inc.

NasdaqCM:GRCE Stock Report

Market Cap: US$32.8m

Grace Therapeutics, Inc. Company Information

Grace Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Grace Therapeutics, Inc.
  • Ticker: GRCE
  • Exchange: NasdaqCM
  • Founded: 2002
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$32.752m
  • Shares Outstanding: 10.14m
  • Website: https://www.acastipharma.com

Number of Employees

Location

  • Grace Therapeutics, Inc.
  • 103 Carnegie Center
  • Suite 300
  • Princeton
  • New Jersey
  • 08540
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GRCENasdaqCM (Nasdaq Capital Market)YesClass A SharesUSUSDMar 2011
L8SDB (Deutsche Boerse AG)YesClass A SharesDEEURMar 2011

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/22 23:36
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2024/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.